Central Florida Lawyer Representing Victims of Zantac Injuries
Currently, there are numerous drugs available, both prescription and over-the-counter, for fighting heartburn. Many of these drugs use a substance known as ranitidine in order to battle stomach ulcers and high acid content. On April 1st of 2020, the Food and Drug Administration issued a recall regarding ranitidine, stating that the chemical poses a sizable risk for spurring the growth of cancer within those who ingest it.
The FDA began its investigation into ranitidine back in the summer of 2019. At that point, a laboratory working independently of the FDA discovered the chemical NDMA within ranitidine, a substance known to cause cancer. When the FDA then conducted its own tests, they initially determined that the levels of NDMA within the ranitidine products was not high enough to lead to an increased cancer risk. In their statement at that time, the FDA declared themselves without sufficient scientific proof that ranitidine would noticeably increase cancer risk in users; however, they cautioned consumers about the possible detrimental effects of ranitidine and suggested people begin using alternate treatments. The FDA concluded their statement by saying they would continue their testing.
This continued testing has resulted in the most recent announcement: a full recall of ranitidine products. This recall most immediately and powerfully affects the Zantac brand of heartburn and ulcer medication.
Among the findings of the FDA’s continued testing, it was reported that NDMA, the carcinogenic substance, begins to rapidly increase within ranitidine over time. If the products are kept refrigerated, the increase is slowed, but it still rises perceptibly. At room temperature, the amount of NDMA within ranitidine skyrockets. Because the length of time drugs are kept in storage is often unknown, the FDA decided that a complete recall was the safest way to handle the situation.
For many decades, the Law Offices of James O. Cunningham, P.A. have represented individuals and families adversely affected or injured by faulty products. Because we rely on things like pharmaceutical drugs to keep us healthy and safe, we often forget that these very drugs might be carriers of things which can harm us. When this happens, when companies such as those that produce Zantac allow individuals to consume potentially lethal products, it is the responsibility of these companies to provide financial support and compensation to those most damaged by their negligence.
James O. Cunningham and his team of legal professionals possess a strong record of representing individuals suffering in just these sorts of situations. With our strong compassion and dedication, we have worked with tenacity to bring such cases to a satisfactory conclusion, with many of the victims receiving substantial compensation for what they suffered.
If you or a loved one have been injured aftering using Zantac products containing ranitidine, you might be eligible to receive repayment for any damages you might sustain as a result. Reach out to us today at 407-425-2000 for a free initial consultation with one of our highly-trained and caring legal representatives.
- Cruise Ship Norovirus Outbreaks Traced Back to Frozen Raspberries
April 29, 2020
- FDA Recalls Zantac Due to Possible Cancer-Causing Carcinogen
April 5, 2020
- Historic Wrongful Death Settlement Reached by Family Against Ikea
January 12, 2020
- Second Death Confirmed in Florida Vaping Incident
December 13, 2019
- Production & Sale of OTC Drug Halted Due To Cancer Concerns
September 23, 2019
- business5Mr. Cunningham is an excellent and knowledgeable attorney.
I would and have recommended Mr. Cunningham as an attorney. I am extremely happy with the service he has provided for me and my family. I will definately use Mr. Cunningham in the future if I ever need an attorney again.
- John, a Personal Injury client0.3